A subscription to JoVE is required to view this content. Sign in or start your free trial.
* These authors contributed equally
This protocol outlines a method for inducing diabetic cardiomyopathy through a combination of high-fat diet feeding and streptozotocin injection. This approach aims to provide a reliable framework for scientific investigation into diabetic cardiomyopathy and to explore potential avenues for clinical treatment applications.
The underlying pathophysiological mechanisms of diabetic cardiomyopathy (DbCM), a leading cause of mortality among patients with type 2 diabetes mellitus (T2DM), remain poorly understood. The myocardial toxicity associated with T2DM is attributed to factors such as lipotoxicity, glucotoxicity, oxidative stress, reduced cardiac efficiency, and lipoapoptosis. Compared to rats, mice offer greater accessibility, cost-effectiveness, and broader applicability for animal experiments. Insulin resistance and impaired insulin secretion are crucial factors in the pathophysiology of T2DM. We introduce a novel nongenetic murine model that replicates the progression of human DbCM induced by a combination of high-fat diet (HFD) feeding and streptozotocin (STZ) injection. In this study, we used wild-type C57BL/6J mice, administering an HFD regimen for 12 weeks, followed by intraperitoneal injections of STZ for an additional 12 weeks to induce characteristic manifestations of T2DM. We conducted oral glucose tolerance tests and measured serum insulin concentrations to confirm the development of insulin resistance and insufficient insulin secretion. Cardiac structure and function were rigorously assessed through noninvasive transthoracic echocardiography. Pathological characteristics were evaluated through Masson's trichrome staining and wheat germ agglutinin (WGA) staining, revealing pathological features related to DbCM. Therefore, we provide a robust and versatile method for establishing a nongenetic murine model of DbCM.
Type 2 diabetes mellitus (T2DM) is a progressively escalating global health concern, standing as a leading cause of morbidity and mortality among affected individuals. The prevalence of T2DM is closely related to the rising epidemic of obesity1,2. More than one-third of patients with T2DM exhibit a distinct cardiovascular phenotype termed diabetic cardiomyopathy (DbCM), characterized by myocardial dysfunction that occurs independently of coronary artery disease, hypertension, and valvular heart disease3. Emerging evidence suggests that approximately 20% of diabetic patients are predispo....
All procedures followed institutional guidelines for animal research in accordance with the Guide for the Care and Use of Laboratory Animals outlined by the US National Institutes of Health (NIH Publication No. 85-23, revised in 1996). All animal experiments were approved by the Ethics Committee of Animal Care and the Ethics Committee of Sichuan University. Male C57BL/6J mice were purchased from Beijing Vital River Laboratory Animal Technology Co. (China). Throughout the experimental duration, mice were housed under cont.......
This study involved random allocation of mice into two groups: the ND group and the HFD/STZ group, with 6 mice in each group. Subsequent to the final echocardiography and OGTT tests 24 weeks after feeding, the mice were euthanatized to harvest their heart tissues for a histological assessment.
HFD/STZ caused an obvious body weight gain, reaching its peak in 12 weeks, and was significantly higher compared with the ND group. Following the administration of STZ, a notable decrease in body weight .......
Given the widespread prevalence of diabetes mellitus and its associated cardiovascular complications globally, there is an urgent need to uncover the underlying molecular mechanisms and develop preventative and therapeutic strategies for this condition20. The pathogenesis of DbCM, one of the cardiovascular complications for patients with T2DM, remains unclear, with no effective approaches to prevent and treat21. The absence of reliable preclinical models that accurately mim.......
This work was supported by the National Natural Science Foundation of China (grant numbers: U23A20395, 81900258, and 82170375); the Key Research and Development Project of Science & Technology Department of Sichuan Province (2022ZDZX0020); Chinese Medical Association Cardiovascular Branch (CSC) Clinical Research Special Fund Project (CSCF2020B04); 1· 3· 5 project of West China Hospital, Sichuan University (ZYGD23021). Thanks to Qing Yang (Animal Imaging Core Facilities, West China Hospital, Sichuan University) for their help in small animal ultrasonography.
....Name | Company | Catalog Number | Comments |
Animal ultrosound system | Fujifilm Visual Sonics | VEVO 3100 | Echocardiography |
Blood glucometer | Yuwell | GU100 | Assess blood glucose level |
Citric acid | Sigma-Aldrich | 251275 | |
Isoflurane | RWD life science | R510-22 | Anesthesia |
Isoflurane vaporizer | RWD life science | R500 | Anesthesia |
Mouse insulin (INS) ELISA Kit | Wuhan Feiyue Biotechnology Co.,Ltd | FY-EM14029 | Assess serum insulin level |
Nair hair removal cream | Nair | 255g | Remove the fur of mouse |
Rodent diet with 60% kcal fat | Research Diets Inc | D12492 | High fat diet feeding |
Sodium citrate | Sigma-Aldrich | S4641 | |
Sterile filter | Merck Millipore | SLHV033N | |
Streptozocin | Solarbio | S8050 | |
Ultrasound gel | Keppler | KL-250 | Echocardiography |
Workstation Dongle | Fujifilm Visual Sonics | Vevo LAB | Echocardiographic data analysis |
Explore More Articles
This article has been published
Video Coming Soon
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved